MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
54 hedge funds and large institutions have $37.9M invested in Merrimack Pharmaceuticals, Inc. in 2019 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 17 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
54
Holders Change
-2
Holders Change %
-3.57%
% of All Funds
1.17%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
8
Increased
11
Reduced
17
Closed
10
Calls
$110K
Puts
$49K
Net Calls
+$61K
Net Calls Change
+$84K
Top Buyers
| 1 |
2L
22NW LP
Seattle,
Washington
|
$7.59M |
| 2 |
WSL
Western Standard LLC
Los Angeles,
California
|
$2.96M |
| 3 |
NM
Newtyn Management
New York
|
$7.96M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
$4.55M |
| 5 |
Invesco
Atlanta,
Georgia
|
$404K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SC
51
Sepio Capital
Salt Lake City,
Utah
| – | -$1.59M | -523,240 | Closed |
|
|
CC
52
Clearline Capital
New York
| – | -$1.22M | -402,176 | Closed |
|
|
JGC
53
J. Goldman & Co
New York
| – | -$587K | -193,313 | Closed |
|
54
Citadel Advisors
Miami,
Florida
| – | -$65K | -21,571 | Closed |
|
55
HighTower Advisors
Chicago,
Illinois
| – | -$58K | -19,129 | Closed |
|
56
Russell Investments Group
London,
United Kingdom
| – | -$18K | -5,974 | Closed |
|
57
Macquarie Group
Sydney, NSW 2000,
Australia
| – | -$6K | -2,034 | Closed |
|